openPR Logo
Press release

UK Cancer Biomarkers Market, Industry Trends, Size, Competitive Analysis and Forecast 2019-2025

02-25-2020 10:31 AM CET | Health & Medicine

Press release from: Orion Market Research

UK Cancer Biomarkers Cancer Biomarker Market

UK Cancer Biomarkers Cancer Biomarker Market

UK cancer biomarker market is expected to grow at a CAGR of around 11.7% during the forecast period. The major factor that is increasing the market is a high prevalence of cancer in the region, well-developed healthcare infrastructure and the presence of the major market players in the nation. Additionally, as the country has developed economy, per capita healthcare investment from government and public is higher than other developing nation and hence significant research can be observed in the near future.

Request a Free Sample of our Report on UK Cancer Biomarkers Market: https://www.omrglobal.com/request-sample/uk-cancer-biomarker-market

The healthcare expenditure of the UK is more than $25,000 million as compared to Germany and France. This is one of the major factors that tend to rise the UK cancer biomarker market. AS per OECD, the prevalence of cancer in the UK is approx. 225 per 100,000 people in 2011 which is estimated to reduce only to 214 per 100,000 people in 2017. The incidences of cancer patients in the UK have been very frequent previously.

The increasing integration of healthcare with technology is augmenting the UK cancer biomarker market. There are various procedures that are being uniquely available at UK treatment centers. For instance, the Clatter Bridge Cancer Centre is one of the first two hospitals in the UK to offer dose painting radiotherapy to patients. The technique is suitable for patients with a higher density of cancer cells, which have not spread from the prostate gland. This applies to 30- 50% of all prostate cancer cases. While an equal amount of radiation is delivered by the standard radiotherapy on the prostate, in dose painting radiotherapy, MRI scans or PET CT scan first identify areas of the prostate which is more affected.

Further, during the year 2016/2017 the Cancer Research UK supported the research based on cancer worth $490.22 million. On the lung cancer research $55.11 million was spent whereas an amount of $44.06 million was spent in the research of colon and rectal cancer. For, breast cancer $ 41.65 million was spent on the research. The funding in the research is expected to motivate the UK market of cancer biomarker. Thus, such contributions by the government organizations is expected to further drive the UK cancer biomarker market.

A Full Report of UK Cancer Biomarkers Market is Available at https://www.omrglobal.com/industry-reports/uk-cancer-biomarker-market

UK Cancer Biomarkers Cancer Biomarker Market Segmentation

By Biomarker Type
o Genetic Biomarker
o Protein Biomarker

By Cancer Type
o Lung Cancer
o Prostate Cancer
o Breast Cancer
o Colorectal Cancer
o Cervical Cancer
o Other

By Applications
o Drug Discovery and Development
o Diagnosis
o Risk Assessment
o Prognostics

By Profiling Technology
o Omics Technology
o Immunoassays
o Cytogenetics
o Bioinformatics

Company Profiles
o Abbott laboratories Inc.
o Astellas Pharma Inc.
o Becton, Dickson and Co.
o Bio-Rad Laboratories, Inc.
o Danaher Corp.
o F. Hoffmann-La Roche Ltd.
o Merck and Co., Inc.
o Novartis AG
o Pfizer Inc.
o QIAGEN GmbH
o Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-cancer-biomarker-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release UK Cancer Biomarkers Market, Industry Trends, Size, Competitive Analysis and Forecast 2019-2025 here

News-ID: 1944001 • Views: 201

More Releases from Orion Market Research

North America Cosmetic Market Industry Trends, Growth, Analysis, Size, Share and …
The cosmetic products are widely used by consumers in North America to enhance the appearance or odor of their bodies. The region is one of the major markets for the cosmetic industry due to high awareness related to their appearance, presence of most of the global players and the high disposable income of the people. Additionally, recent trends to use natural ingredients in cosmetic products observed among manufacturers have also
North America Aviation Market Trends, Analysis, Growth, Size, Share and Forecast …
North America aviation industry includes airline companies, airport managing companies, and aircraft manufacturing companies along with the companies involved in the management of the airport and aircraft. The factors that were fueling the growth of the market before the COVID-19 pandemic include the expected capacity growth owing to new aircraft deliveries, lowered operating costs, and grounding of older airplanes, and increased fuel-efficient aircraft. Additionally, increased economic activity and a growing
Impact of COVID-19 on Middle East Countries Market Trends, Growth, Analysis and …
Iran: According to the Iranian health ministry update, till 24th March 2020, the total number of people diagnosed with the coronavirus has reached 24,811, out of whom 1,934 have died in Iran. In order to fight with the covid-19 outbreak the government of Iran is ramping up its health spending, providing additional funding to its Ministry of Health. Get Sample Copy of Impact of COVID-19 on Middle East Countries Market at:
Cosmetic Market - Global Industry Analysis, Size, Share, Growth, Trends and Fore …
As the spread and complexity of the COVID-19, continues to develop, many businesses dealing in cosmetic industry are implement new safety measures. The safety measures taken by cosmetic companies include frequent disinfection of the stores and service limitation, urge social distancing for employees. Some of the businesses are even closed down for the foreseeable future. Glossier is one of many businesses that is opting to close all Glossier shops until

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and